Bal Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹87.69 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.47 per cent from ₹74.02 crore. This corresponds to a year-on-year *(YoY) growth of 19.88 per cent.
Operating Profit
Operating Profit stands at ₹9.55 crore, reflecting a quarter-on-quarter *(QoQ) increase of 66.67 per cent from ₹5.73 crore. This corresponds to a year-on-year *(YoY) growth of 23.23 per cent.
PBDT
PBDT stands at ₹5.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 67.89 per cent from ₹2.99 crore. This corresponds to a year-on-year *(YoY) growth of 54.46 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 148.61 per cent from ₹0.72 crore. This corresponds to a year-on-year *(YoY) growth of 219.64 per cent.
Net Profit
Net Profit stands at ₹1.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 148.61 per cent from ₹0.72 crore. This represents a 244.23 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Bal Pharma Ltd Earnings
- YOY
- QOQ
Bal Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Bal Pharma Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Bal Pharma Ltd Financial Reports
Bal Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Bal Pharma | 0.00% | -0.22% | 18.11% | 11.31% | -7.40% | -23.91% |
| Achyut Healthcar | -0.18% | 2.43% | -1.26% | 4.78% | -0.90% | 54.37% |
| Tyche Industries | -2.37% | -4.61% | 9.73% | 16.64% | -8.04% | -14.67% |
| Godavari Drugs | -2.91% | 4.51% | 33.01% | 43.04% | 42.28% | 38.52% |
| Novelix Pharma. | -1.70% | -1.94% | 3.29% | -8.29% | 4.64% | 106.69% |
| Concord Drugs | -1.00% | 0.76% | 19.90% | 10.56% | 27.04% | 184.24% |
| Denis Chem Lab | 1.79% | 1.88% | 16.31% | 2.93% | -14.75% | -21.82% |
Company Info
Company Information
ED / MD / Promoter : Shailesh Siroya
E D & Wholetime Director : Himesh Virupakshaya
Independent Non Exe. Director : H S Venkatesh
Independent Non Exe. Director : Nicola Neeladri
Independent Non Exe. Director : Jatish Sheth
Independent Non Exe. Director : Ravindrakumar Kothari
Company Sec. & Compli. Officer : Abdul Basith
Additional Director : Bheekamchand Mukesh